| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |